Global Auto-Injector Market Analysis and Forecast of $ 5.95 Billion, 2015-2020, 2020-2025F, 2030F

DUBLIN, December 24, 2021 / PRNewswire / – The “Global Auto-Injector Market Report 2021: Implications and Growth of COVID-19” the report was added to ResearchAndMarkets.com offer.

Research and Markets logo

The global auto-injector market is expected to grow by $ 2.42 billion in 2020 at $ 2.94 billion in 2021 at a compound annual growth rate (CAGR) of 21.3%. The market is expected to reach $ 5.95 billion in 2025 at a CAGR of 19.3%.

The major players in the auto-injector market are AbbVie, Mylan, Eli Lilly and Company, Amgen, Becton Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical, Merck, Pfizer, Bayer, Biogen and AstraZeneca.

The auto-injector market includes the sales of auto-injectors by entities (organizations, independent traders, and partnerships) designed to help people overcome their fear of using a drug delivery system on their own. ‘needles. An auto-injector is a device that allows you to inject a single, predefined dose of medicine into your own body. It usually consists of a spring loaded syringe that is activated when the device is pressed firmly against the body.

The main types of auto-injectors are disposable auto-injectors and reusable auto-injectors. The disposable auto-injector market includes sales of disposable auto-injectors by entities (organizations, independent traders, and partnerships) designed to replace traditional pre-filled syringes and remove psychological barriers by removing the needle from the patient’s sight.

Disposable auto-injectors combine a spring-loaded power source with a shielded needle that delivers the required drug solution subcutaneously or intramuscularly. The different therapies include rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, other therapies and are administered by various routes such as subcutaneous, intramuscular. These are sold to customers through online retailer and pharmacy and are implemented in various verticals such as home care facilities, hospitals and clinics etc.

North America was the largest region of the auto-injector market in 2020. Asia Pacific is expected to be the fastest growing region during the forecast period. Growing technological advancements are shaping the auto-injector market. The major players operating in the auto-injector industry are focused on developing technological solutions for auto-injectors to meet the demand for a viscous biologic delivery mechanism.

In march 2020, SHL medical, a Switzerlandsupplier of advanced delivery devices, such as auto-injectors, pen injectors, advanced inhalers and portable drug delivery systems, has acquired Weibel CDS for an undisclosed amount. With this acquisition, SHL is expected to expand its portfolio of innovative drug delivery solutions for injection devices. Weibel CDS is a Swiss medical technology company specializing in the research and development of patch injection systems and devices.

The increasing prevalence of chronic diseases is expected to fuel the growth of the auto-injector market in the coming years. Chronic illnesses are described as illnesses that last a year or more and require ongoing medical care. Chronic diseases such as heart disease, cancer, rheumatoid arthritis, and diabetes are the leading causes of death and disability around the world.

The self-injection devices are intended for multiple injections of biologics and hormones in patients who require regular dosing for the long-term management of medical circumstances such as diabetes and rheumatoid arthritis. Hence, the increasing prevalence of chronic diseases is driving the growth of the auto-injector market.

Main topics covered:

1. Summary

2. Characteristics of the auto-injector market

3. Auto-Injector Market Trends and Strategies

4. Impact of COVID-19 on auto-injectors

5. Size and growth of the auto-injector market
5.1. Global historical auto-injector market, 2015-2020, in USD billion
5.1.1. Market pilots
5.1.2. Market restrictions
5.2. Global Auto-Injector Forecast Market, 2020-2025F, 2030F, in USD Billion
5.2.1. Market pilots
5.2.2. Market restrictions

6. Segmentation of the auto-injector market
6.1. Global Auto-Injector Market, Segmentation by Type, History and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion

  • Disposable auto-injectors

  • Reusable auto-injectors

6.2. Global Auto-Injector Market, Segmentation by Therapy, History and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion

  • Rheumatoid arthritis

  • Multiple sclerosis

  • Diabetes

  • Anaphylaxis

  • Other therapies

6.3. Global Auto-Injector Market, Segmentation by Administration, History and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion

  • Subcutaneous

  • Intramuscular

6.4. Global Auto-Injector Market, Distribution Channel Segmentation, History and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion

6.5. Global Auto-Injector Market, Segmentation by End User, History and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion

  • Home care settings

  • Hospitals and clinics

  • Others

7. Regional and national analysis of the auto-injector market
7.1. Global auto-injector market, divided by region, historical and forecast, 2015-2020, 2020-2025F, 2030F, in USD billion
7.2. Global auto-injector market, divided by country, historical and forecast, 2015-2020, 2020-2025F, 2030F, in USD billion

Companies mentioned

For more information on this report, visit https://www.researchandmarkets.com/r/mq6b8w

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1907
Fax (outside the United States): + 353-1-481-1716

Cision

Cision

Show original content:https://www.prnewswire.com/news-releases/global-5-95-bn-autoinjectors-markets-analysis–forecasts-2015-2020–2020-2025f-2030f-301450721.html

SOURCE Research and Markets


Source link

Comments are closed.